Perimeter Medical Imaging AI Inc
- LAST PRICE0.4400
- TODAY'S CHANGE (%)0.0050 (1.1494%)
- Bid / Lots0.4400/ 1
- Ask / Lots0.4600/ 4
- Open / Previous Close0.4300 / 0.4350
- Day Range
- 52 Week Range
- Volume5,500
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PINK |
|---|---|---|
| 02:30 ET | 5000 | 0.43 |
| 03:08 ET | 500 | 0.44 |
Nov 8, 2024
Perimeter Medical Imaging AI to Report Third Quarter 2024 Financial Results and Host Conference Call on November 14, 2024, from 8:00AM ET on Friday Nov 08, 2024 by Dow Jones
8:00AM ET on Friday Nov 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Perimeter Medical Imaging AI Inc | 40.6M | -1.8x | --- |
Theralase Technologies Inc | 60.2M | -14.7x | --- |
MedMira Inc | 61.3M | -18.0x | --- |
Cannabix Technologies Inc | 45.0M | -11.7x | --- |
Treatment.com AI Inc | 28.0M | -2.2x | --- |
VentriPoint Diagnostics Ltd | 22.6M | -4.4x | --- |
Company Information
Perimeter Medical Imaging AI, Inc. is a medical technology company driven to transform cancer surgery with resolution, real-time, imaging tools to address high unmet medical needs. It develops and commercializes in-procedural medical imaging tools. The Company’s Perimeter Optical Coherence Tomography (OCT) system, which provides cross-sectional, real-time margin visualization of tissue microstructures during surgical procedures. The Perimeter S-Series OCT is designed to provide surgeons with the clinical support they need in the OR. The OCT medical imaging system includes an intraoperative device for automated scanning of a tissue specimen that provides a rapid subsurface map of up to a 10 cm by 10 cm surface area; a specimen-handling consumable designed to hold and maintain orientation of the specimen, and an image library and training set. Its machine learning tools and artificial intelligence technology, called ImgAssist AI, through clinical development under its ATLAS AI project.
Contact Information
- Headquarters
- 555 Richmond Street W., Suite 511TORONTO, ON, Canada M5V 3B1
- Phone
- 214-845-5154
- Fax
- ---
Executives
- Independent Chairman of the Board
- Suzanne Foster
- Chief Executive Officer, Director
- Adrian Mendes
- Chief Executive Officer, Director
- Thomas Boon
- Vice President - Clinical and Medical Affairs
- Sarah Butler
- Independent Director
- Hugh Cleland
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.6M |
|---|---|
Revenue (TTM) | $702.2K |
Shares Outstanding | 93.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.56 |
EPS | $-0.24 |
Book Value | $0.32 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 57.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,824.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
